| Net Cash Provided by (Used in) Operating Activities |
$113,382 |
USD |
65% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$180,000 |
USD |
61% |
Q2 2024 |
Q1 2026 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q4 2025 |
Q3 2026 |
| Common Stock, Shares, Issued |
43,063,441 |
shares |
0% |
Q4 2025 |
Q3 2026 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
Q3 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$113,382 |
USD |
22% |
Q2 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$40,287 |
USD |
-84% |
Q4 2025 |
Q3 2026 |
| Deferred Tax Assets, Valuation Allowance |
$9,009,981 |
USD |
11% |
Q1 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$8,080,869 |
USD |
6% |
Q1 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q4 2025 |
Q3 2026 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q4 2025 |
Q3 2026 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q1 2025 |
FY 2025 |
| Additional Paid in Capital |
$32,545,669 |
USD |
2.6% |
Q4 2025 |
Q3 2026 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2025 |
Q3 2026 |
| Interest Expense |
$410,856 |
USD |
25% |
Q1 2024 |
FY 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
Q3 2026 |